For facial rosacea and fine telangiectasias, configure IPL conservatively with a double-pulse sequence, active cooling, and approximately 40 days between sessions. A commonly cited starting range is 14–18 J/cm², delivered as two pulses of about 5–8 ms each with a 10–20 ms inter-pulse delay. The usual course is 2–4 sessions, often three, with each treatment separated by roughly 40 days to allow vascular response and skin recovery.
The safest practical approach is to prioritize the intended clinical endpoint over a fixed number: use device-appropriate fluence and pulse timing to produce mild, transient erythema and limited localized edema, while avoiding blanching, gray discoloration, blistering, or excessive inflammation.
How to Configure the Pulse Sequence
Select a Double-Pulse Pattern
A double-pulse sequence allows energy to be delivered in controlled stages rather than as one concentrated pulse. For the facial vessels described, use pulse durations of approximately 5–8 ms with an inter-pulse delay of 10–20 ms, subject to the specific device and treatment protocol.
The delay gives heat time to dissipate partially from the epidermis and surrounding tissue while the vascular target remains exposed to therapeutic photothermal stress.
Set Fluence Within a Conservative Range
A practical fluence range is 14–18 J/cm². Specialized vascular IPL systems may commonly use 15–18 J/cm², but the correct setting depends on the device, filter, spot size, skin type, vessel characteristics, and cooling performance.
Fluence should be adjusted to the patient and observed response rather than applied as a universal prescription. Treatment should begin at the lower end when there is increased risk of pigmentary or thermal injury.
Use Integrated Cooling Continuously
Active integrated cooling should accompany vascular IPL treatment. Cooling protects the epidermis, improves patient comfort, and permits more controlled delivery of energy to dermal vessels.
Cooling does not compensate for excessive fluence, an unsuitable filter, or incorrect pulse timing. It is one part of the safety system, not a reason to exceed established device limits.
Match Settings to the Vascular Target
Consider Vessel Size and Depth
Fine facial telangiectasias are generally superficial and small, so millisecond pulse durations are appropriate. Smaller vessels can respond to shorter pulses, while larger or deeper vessels generally require longer exposure times to heat the vessel wall adequately.
For rosacea, the treatment target may include both superficial telangiectasias and more diffuse vascular redness. Filter selection and pulse configuration should therefore be based on the dominant vascular pattern rather than on fluence alone.
Choose the Appropriate Filter
IPL systems emit a broad spectrum, and cutoff filters determine which wavelengths reach the skin. Filters in the approximately 550–570 nm range are commonly used for superficial vascular targets, while longer wavelengths penetrate more deeply and reduce relative absorption by epidermal melanin.
The filter should be selected according to vessel depth, diameter, skin pigmentation, and the manufacturer’s validated protocol. Wavelength, fluence, pulse duration, and cooling function as a combined treatment system.
Use Clinical Endpoints as Feedback
The desired immediate response is typically mild, transient erythema with possible mild localized edema. These findings indicate vascular photothermal absorption without necessarily indicating excessive injury.
Blanching, gray or white discoloration, crystal-shaped erythema, blistering, or marked pain are warning signs. Treatment should be stopped and the parameters reassessed if these findings occur.
Plan the Treatment Schedule
Space Sessions Approximately 40 Days Apart
A spacing interval of approximately 40 days allows time for the treated vessels to undergo clearance and for the skin barrier to recover. Treating again too soon can make inflammation and adverse effects difficult to distinguish from the intended vascular response.
The interval should also account for persistent erythema, edema, pigmentary change, crusting, or other delayed reactions. A patient should not be retreated simply because the nominal interval has elapsed if the skin has not adequately recovered.
Use Two to Four Sessions as a Typical Course
A standard course consists of 2–4 sessions, with three sessions being a common treatment plan for facial rosacea and fine telangiectasias. The final number should be determined by the response after each session and the persistence of vascular findings.
Maintenance treatments may be considered separately from the initial course, but they should not be scheduled automatically without reassessing the clinical response and skin condition.
Understanding the Trade-offs
Higher Fluence Can Increase Clearance and Injury Risk
Increasing fluence may improve treatment of resistant vessels, but it also increases epidermal heating and the risk of burns, blistering, scarring, and post-inflammatory pigmentary change.
A visible endpoint should remain mild and controlled. Escalation should be gradual and performed only within the device manufacturer’s protocol and the operator’s clinical training.
Shorter Pulses Are Not Automatically Better
Short pulses can deliver high peak power and may be useful for small superficial vessels, but they can also increase the risk of purpura or excessive localized heating. Pulse duration must be matched to the target rather than minimized by default.
Longer pulses may be more appropriate for larger vessels, but settings used for leg telangiectasias should not be transferred directly to fine facial vessels. Vessel depth, diameter, skin thickness, and treatment site materially change the correct configuration.
Skin Type and Tanning Affect Safety
Vascular IPL treatments require particular caution in Fitzpatrick skin types IV–VI and tanned skin, where epidermal melanin competes for light absorption. The risks include blistering, scarring, and persistent hyperpigmentation or hypopigmentation.
Recent tanning, pigmentary disorders, photosensitizing medications, and a history of abnormal scarring should be assessed before treatment. Device-specific contraindications and manufacturer limits take precedence over generalized parameter ranges.
Device Specifications Limit Transferability
The same fluence and pulse sequence can produce different outcomes on different IPL platforms because of differences in spectrum, filter design, spot size, pulse shape, cooling, and calibration.
The ranges above should therefore be treated as reference parameters, not a stand-alone treatment prescription. A qualified clinician should verify the device protocol, perform appropriate patient assessment, and use a test area when indicated.
How to Apply This to Your Project
The settings should be selected as a controlled starting framework and then refined according to the device, patient, and observed endpoint.
- If your primary focus is vascular clearance: Use a device-validated fluence around 14–18 J/cm² with a double pulse of approximately 5–8 ms, a 10–20 ms delay, and active cooling, while targeting mild transient erythema rather than aggressive tissue change.
- If your primary focus is patient safety and comfort: Begin conservatively, maintain effective cooling, reassess skin response during treatment, and reduce or stop treatment if blanching, graying, crystal-shaped erythema, blistering, or disproportionate pain appears.
- If your primary focus is treatment planning: Plan 2–4 sessions, commonly three, at approximately 40-day intervals, with retreatment determined by recovery and clinical response.
- If your primary focus is pigment-risk reduction: Exercise heightened caution with darker or recently tanned skin, confirm the appropriate filter and protocol, and avoid applying facial vascular settings indiscriminately to other body sites.
Effective IPL treatment comes from matching fluence, pulse timing, wavelength, cooling, and session spacing to the individual vascular target rather than relying on a fixed setting.
Summary Table:
| Parameter | Recommended Setting | Purpose |
|---|---|---|
| Pulse sequence | Double-pulse | Controlled energy delivery |
| Pulse duration | 5–8 ms per pulse | Matches vessel thermal relaxation |
| Inter-pulse delay | 10–20 ms | Allows epidermal cooling |
| Fluence | 14–18 J/cm² | Effective vascular heating |
| Filter | 550–570 nm for superficial vessels | Selects wavelengths for target depth |
| Cooling | Active, continuous | Protects epidermis |
| Session spacing | ~40 days | Allows vascular clearance and skin recovery |
| Number of sessions | 2–4 (commonly 3) | Achieves optimal clearance |
Discover how BELIS's advanced IPL systems can enhance your clinic's vascular treatments. Our devices are designed for precision and safety, featuring optimized pulse control and integrated cooling to help you achieve superior patient outcomes. Whether you're treating rosacea, telangiectasias, or other aesthetic concerns, our portfolio—from IPL to laser and body contouring—covers every need for clinics and premium salons. Partner with us for reliable, certified equipment and expert support. Contact us today to learn more about our solutions and take your practice to the next level.
Related Products
- IPL SHR Hair Removal Machine for Permanent Hair Removal
- Professional IPL SHR Hair Removal Machine for Laser and IPL Hair Removal
- IPL SHR+Radio frecuency machine
- Trilaser Diode Hair Removal Machine for Beauty Clinic Use
- Clinic Use IPL SHR ND YAG Laser Hair Removal RF Skin Tightening Machine
People Also Ask
- How does an IPL SHR machine achieve long-term hair reduction compared to traditional methods? Professional Tech Guide
- How does the frequency of IPL SHR sessions compare to traditional laser hair removal? Maximize Comfort and Efficiency
- How does IPL SHR technology accommodate a wide range of skin types and hair colors? Safe Solutions for All Skin Tones
- How does the safety mechanism of IPL SHR technology protect the surrounding skin tissue? Advanced Protection Guide
- Why is the IPL SHR hair removal process described as painless and comfortable for the patient? Discover the Tech.